1991年，第一例腹腔镜胆囊手术在中国大陆成功完成，标志着中国外科迈入了微创时代。随着30年来手术技术及腔镜设备的不断创新，腹腔镜手术已经成熟应用于右半结肠肿瘤的外科治疗。与开腹手术相比，严格遵守手术操作规范以及手术质量控制，腹腔镜右半结肠D3+完整结肠系膜切除术(CME)手术并不增加并发症和手术时间，可以将微创和根治做到极致，取得令人满意的近期、远期临床效果。腹腔镜手术微创、精准、可复制等优势和特点已经成为业界的共识。未来随着分子影像学、术中导航技术、手术机器人深度学习等高科技的发展和迭代衍生，结肠癌乃至肿瘤外科的整体治疗体系都会不断更新和完善，最终更好地造福于患者。

In 1991, the first case of laparoscopic cholecystectomy was successfully performed in mainland China, which was recognized as the era of minimally invasive surgery in China. With the continuous innovation of surgical technology and endoscopic equipment in the past 30 years, laparoscopic surgery has been mature and applied to the surgical treatment of right colon tumors. Compared with laparotomy, laparoscopic right colon D3 + CME operation does not increase complications and operation time, however could achieve the ultimate minimally invasive and radical operation, and could achieve satisfactory short-term and long-term clinical outcome. The advantages and characteristics of laparoscopic surgery, such as minimally invasive, accurate and reproducible, have become the consensus. In the future, with the development and iterative derivation of high technologies such as molecular imaging, intraoperative navigation technology and deep learning of surgical robots, therapuetic treatment system of colon cancer and even tumor surgery would be continuously updated and improved, finally could better benefit patients.